Duration of therapy is up to 14 days or until hospital discharge
Dose dependent on eGFR
eGFR ≥60 mL/min/1.73 m2: 4 mg PO once daily
eGFR 30 to <60 mL/min/1.73 m2: 2 mg PO once daily
eGFR 15 to <30 mL/min/1.73 m2: 1 mg PO once daily
eGFR <15 mL/min/1.73 m2: Not recommended.
eGFR ≥60 mL/min/1.73 m2: 4 mg PO once daily
eGFR 30 to <60 mL/min/1.73 m2: 2 mg PO once daily
eGFR 15 to <30 mL/min/1.73 m2: 1 mg PO once daily
eGFR <15 mL/min/1.73 m2: Not recommended.
Baricitinib
Raxibacumab
Rasburicase
Sarilumab
Phosgene
Rituximab
Idarucizumab
Levoleucovorin